Literature DB >> 3257351

Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon.

K Satoh1, T Nukiwa, M Brantly, R I Garver, M Hofker, M Courtney, R G Crystal.   

Abstract

Homozygous inheritance of the null bellingham alpha 1-antitrypsin (alpha 1AT) gene is associated with early-onset emphysema, resulting from the lack of alpha 1AT to protect the lung from neutrophil elastase. Cloning and sequencing of the null bellingham gene demonstrated that the promoter region, coding exons, and all exon-intron junctions were normal except for a single base substitution in exon III, causing the normal lys217 (AAG) to become a stop codon (TAG). Evaluation of genomic DNA of family members by using oligonucleotides directed toward this region demonstrated that the index case had inherited this mutation in a homozygous fashion. Although the consequences to the individual (i.e., emphysema) are identical to those associated with the common homozygous Z mutation, the homozygous null bellingham form of alpha 1AT deficiency has a very different genetic basis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257351      PMCID: PMC1715304     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  32 in total

1.  Further examples confirming the existence of Pi null (Pi-).

Authors:  J P Martin
Journal:  Pathol Biol (Paris)       Date:  1975-09

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  1 -Antitrypsin deficiency: a variant with no detectable 1 -antitrypsin.

Authors:  R C Talamo; C E Langley; C E Reed; S Makino
Journal:  Science       Date:  1973-07-06       Impact factor: 47.728

Review 4.  The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin.

Authors:  M K Fagerhol; D W Cox
Journal:  Adv Hum Genet       Date:  1981

5.  Report of Nomenclature Meeting for alpha 1-antitrypsin, INSERM, Rouen/Bois-Guillaume-1978.

Authors:  D W Cox; A M Johnson; M K Fagerhol
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

6.  Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z.

Authors:  J O Jeppsson; C B Laurell; M Fagerhol
Journal:  Eur J Biochem       Date:  1978-02-01

7.  Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

Authors:  C Larsson
Journal:  Acta Med Scand       Date:  1978

Review 8.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

9.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia.

Authors:  L E Maquat; A J Kinniburgh; E A Rachmilewitz; J Ross
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  23 in total

1.  Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) Null(Newport) (Gly115----Ser) and (Pi) Z Wrexham (Ser-19----Leu).

Authors:  A Graham; N A Kalsheker; F J Bamforth; C R Newton; A F Markham
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

Review 2.  Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

Authors:  N Kalsheker; K Morgan
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.

Authors:  A Hamosh; B C Trapnell; P L Zeitlin; C Montrose-Rafizadeh; B J Rosenstein; R G Crystal; G R Cutting
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys).

Authors:  A Graham; N A Kalsheker; C R Newton; F J Bamforth; S J Powell; A F Markham
Journal:  Hum Genet       Date:  1989-12       Impact factor: 4.132

5.  Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.

Authors:  D Curiel; M Brantly; E Curiel; L Stier; R G Crystal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  A Pro----Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen.

Authors:  M H Hofker; T Nukiwa; H M van Paassen; M Nelen; J A Kramps; E C Klasen; R R Frants; R G Crystal
Journal:  Hum Genet       Date:  1989-02       Impact factor: 4.132

7.  Rare deficiency types of alpha 1-antitrypsin: electrophoretic variation and DNA haplotypes.

Authors:  D W Cox; G D Billingsley
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

8.  In-frame single codon deletion in the Mmalton deficiency allele of alpha 1-antitrypsin.

Authors:  G C Fraizer; T R Harrold; M H Hofker; D W Cox
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

9.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

10.  A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds.

Authors:  L M Nogee; G Garnier; H C Dietz; L Singer; A M Murphy; D E deMello; H R Colten
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.